NASDAQ: MURAMural Oncology PLC Stock Ownership - Who owns Mural Oncology?
Insider buying vs selling
Have Mural Oncology PLC insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when MURA insiders and whales buy or sell their stock.
MURA Shareholders
What type of owners hold Mural Oncology PLC stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Westfield Capital Management Co LP | 11.74% | 1,985,886 | $7.01M | Institution |
| Armistice Capital LLC | 9.80% | 1,658,000 | $5.85M | Institution |
| Vanguard Group Inc | 9.01% | 1,524,017 | $5.38M | Institution |
| Blackrock Inc | 6.93% | 1,173,007 | $4.14M | Institution |
| Alta Fundamental Advisers LLC | 3.55% | 600,000 | $2.12M | Institution |
| Newtyn Management LLC | 2.63% | 445,000 | $1.57M | Institution |
| Prosight Management LP | 2.47% | 418,505 | $1.48M | Institution |
| Bank Of New York Mellon Corp | 2.36% | 399,462 | $1.41M | Institution |
| State Street Corp | 2.23% | 377,586 | $1.33M | Institution |
| Geode Capital Management LLC | 2.11% | 356,367 | $1.26M | Institution |
MURA vs Biotech Stocks
Mural Oncology Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.